CH McCabe

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Frans Van de Werf

KU Leuven

Robert P. Giugliano

Thrombolysis in Myocardial Infarction Study Group

CP Cannon

Baim Institute for Clinical Research

C. Michael Gibson

Beth Israel Deaconess Medical Center

Eugene Braunwald

Brigham and Women's Hospital

Eugene Braunwald

Brigham and Women's Hospital

C.P. Cannon

Thrombolysis in Myocardial Infarction Study Group

Michael Gibson

Sutter Medical Center

Anthony Sparano

Children's Hospital of Philadelphia

Susan J. Marble

Hadassah Medical Center

Cooperative Institutions

Harvard University

Brigham and Women's Hospital

Thrombolysis in Myocardial Infarction Study Group

Clinical Research Institute

Massachusetts General Hospital

Daiichi Sankyo (United States)

Duke University

Henry Ford Hospital

University of Colorado Denver

Yale University

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Higher Weight Adjusted Doses of TNK are Associated with Improved Non-Culprit, Global and Post PTCA Flow in Addition to Improved Culprit Flow

Circulation (1998)

C. Michael Gibson MJ Rizzo Ryan Ka MB Kelley SJ Marble

Culprit

Source

Cite

Citations (0)

Dose ranging study of intravenous RPR 109891 in patients with acute coronary syndromes — results of TIMI 15A

Journal of the American College of Cardiology (1998)

Robert P. Giugliano CH McCabe R F Sequeira Timothy D. Henry Robert N. Piana

TIMI

Dose-ranging study

10.1016/s0735-1097(98)81050-4

Cite

Citations (4)

The range of QCA velocities for TIMI grades 2 & 3 flow

Journal of the American College of Cardiology (1998)

John Moynihan Kathryn A. Ryan Anthony Sparano Mary E. Kelley Michael J. Rizzo

TIMI

10.1016/s0735-1097(98)80698-0

Cite

Citations (1)

Abciximab (ReoPro) potentiates thrombolysis in ST elevation myocardial infarction: results of TIMI 14 trials

Journal of the American College of Cardiology (1998)

Elliott M. Antman Robert P. Giugliano CH McCabe Michael Gibson Aa Jennifer Adgey

Abciximab

TIMI

10.1016/s0735-1097(98)81469-1

Cite

Citations (35)

Abciximab improves both epicardial flow and myocardial reperfusion in ST elevation myocardial infarction: a TIMI 14 analysis

Circulation (1999)

emos de EM Antman C. Michael Gibson CH McCabe Robert P. Giugliano

TIMI

Abciximab

Coronary circulation

Source

Cite

Citations (12)

Early Initiation of Lipid-lowering Therapy for Acute Coronary Syndromes Improves Compliance With Guideline Recommendations: Observations From the Orbofiban in Patients With Unstable Coronary Syndromes (OPUS–TIMI-16) Trial

ACC Current Journal Review (2005)

Craig S. Smith C.P. Cannon CH McCabe Sabina A. Murphy J. Bentley

TIMI

Guideline

Opus

10.1016/j.accreview.2005.08.002

Cite

Citations (0)

Abciximab (Reopro) Achieves Effective Platelet Inhibition in St-Elevation MI: A TIMI 14 Substudy

Circulation (1998)

SA Coulter CP Cannon Frans Van de Werf Adgey Aa J Scherer

Abciximab

TIMI

Platelet inhibition

Source

Cite

Citations (1)

Flow distal and not proximal to the lesion is a correlate of clinical outcomes after thrombolysis

Journal of the American College of Cardiology (1998)

Michael Gibson Anthony Sparano Kathryn A. Ryan John Moynihan Michael J. Kelley

10.1016/s0735-1097(98)80492-0

Cite

Citations (1)

Weight-based dosing of thrombolysis: how well do we estimate weight? How often would this translate into errors with administration of thrombolytic drugs? A comparison of single-bolus TNK with t-PA in TIMI 10B

Journal of the American College of Cardiology (2001)

CP Cannon C. Michael Gibson SA Murphy Frans Van de Werf CH McCabe

Bolus (digestion)

Source

Cite

Citations (1)

TNK-tissue plasminogen activator compared with front-loaded tissue plasminogen activator in acute myocardial infarction: primary results of the TIMI 10B trial

Circulation (1997)

CP Cannon CH McCabe C. Michael Gibson Aa Jennifer Adgey MJ Schweiger

TIMI

Source

Cite

Citations (14)